WOLFGANG WINKELMAYER to Clinical Trials as Topic
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Clinical Trials as Topic.
Connection Strength
0.664
-
Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals. Nephrol Dial Transplant. 2020 10 01; 35(10):1761-1769.
Score: 0.130
-
Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop. Am J Kidney Dis. 2020 07; 76(1):109-120.
Score: 0.127
-
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017 08; 92(2):297-305.
Score: 0.104
-
Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey. Am J Kidney Dis. 2017 Oct; 70(4):464-475.
Score: 0.101
-
Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis. Trials. 2015 Aug 19; 16:364.
Score: 0.091
-
Surrogate markers in clinical studies: problems solved or created? Am J Kidney Dis. 2006 Jul; 48(1):159-66.
Score: 0.048
-
Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease. Expert Opin Investig Drugs. 2000 Nov; 9(11):2637-51.
Score: 0.033
-
Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 05; 95(5):1027-1036.
Score: 0.029